Skip to main content
VulnerabilityPublished Updated

CVE-2023-6078: Dassault Systèmes BIOVIA Materials Studio products · OS Command Injection

Affects Dassault Systèmes BIOVIA Materials Studio productsSource CVE Database V5

0

Not known to be exploited · CVSS 8.8 High.

Data as of 26 Oct 2026, 17:16 UTC

CVSS 3.1 base score
8.8High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
1.6% chance of exploitation in 30 days – higher than 76% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 1 Feb 2024

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

AI-suggested

  1. Immediate Restriction of Access: Limit access to BIOVIA Materials Studio installations to trusted users only, enforcing strict role-based access controls to minimize the number of users with privileges capable of uploading scripts.
  2. Network Segmentation: Isolate systems running BIOVIA Materials Studio from broader enterprise networks to contain potential compromises and prevent lateral movement.
  3. Input Validation and Monitoring: Implement application-layer controls to detect and block uploads of suspicious or unauthorized script files, especially Perl scripts.
  4. Privilege Management: Review and minimize user privileges on affected systems to the least necessary, reducing the risk of exploitation.
  5. Incident Detection: Deploy host-based and network-based intrusion detection systems tuned to identify unusual command execution patterns or script uploads related to BIOVIA.
  6. Vendor Coordination: Engage with Dassault Systèmes for timely updates and patches; monitor official channels for patch releases and apply them promptly once available.
  7. Temporary Workarounds: If feasible, disable or restrict the script upload functionality until a patch is applied.
  8. Security Awareness: Train users on the risks of uploading untrusted scripts and the importance of following security policies. These measures, combined, will reduce the attack surface and mitigate the risk until a vendor patch is released.

Description

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

References

Community reviews

Loading reviews…